These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 31703179)

  • 1. Translating Evidence into Practice: Insights on the Reporting of Trial Results to Health Professionals and Institutions.
    Firmino-Machado J; Mendes R; Moreira A; Lunet N
    Acta Med Port; 2019 Nov; 32(11):683-685. PubMed ID: 31703179
    [No Abstract]   [Full Text] [Related]  

  • 2. Publication of clinical trials: accountability and accessibility.
    Tumber MB; Dickersin K
    J Intern Med; 2004 Oct; 256(4):271-83. PubMed ID: 15367169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of mixed methods in pragmatic trials and dissemination and implementation research.
    Albright K; Gechter K; Kempe A
    Acad Pediatr; 2013; 13(5):400-7. PubMed ID: 24011744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the design and reporting of pragmatic trials in osteoarthritis research.
    Ali SA; Kloseck M; Lee K; Walsh KE; MacDermid JC; Fitzsimmons D
    Rheumatology (Oxford); 2018 Jan; 57(1):59-63. PubMed ID: 28371879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissemination of trial results to participants in phase III pragmatic clinical trials: an audit of trial investigators intentions.
    Raza MZ; Bruhn H; Gillies K
    BMJ Open; 2020 Feb; 10(1):e035730. PubMed ID: 32014881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advancing Organizational Cultural Competency With Dissemination and Implementation Frameworks: Towards Translating Standards into Clinical Practice.
    Ogbolu Y; Fitzpatrick GA
    ANS Adv Nurs Sci; 2015; 38(3):203-14. PubMed ID: 26244477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Data sharing, year 1--access to data from industry-sponsored clinical trials.
    Strom BL; Buyse M; Hughes J; Knoppers BM
    N Engl J Med; 2014 Nov; 371(22):2052-4. PubMed ID: 25317745
    [No Abstract]   [Full Text] [Related]  

  • 8. Bridging the gap between research and practice.
    Braillon A
    Am J Med; 2011 Nov; 124(11):e15. PubMed ID: 21684514
    [No Abstract]   [Full Text] [Related]  

  • 9. Researchers' views of the acceptability of restrictive provisions in clinical trial agreements with industry sponsors.
    Mello MM; Clarridge BR; Studdert DM
    Account Res; 2005; 12(3):163-91. PubMed ID: 16634168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Media coverage and public reaction to a celebrity cancer diagnosis.
    Metcalfe D; Price C; Powell J
    J Public Health (Oxf); 2011 Mar; 33(1):80-5. PubMed ID: 20679285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines for clinical investigator involvement in industry-sponsored clinical trials. SAEM Research Committee.
    Panacek EA; Lewis RJ
    Acad Emerg Med; 1995 Jan; 2(1):43-5. PubMed ID: 7606612
    [No Abstract]   [Full Text] [Related]  

  • 12. The new paradigm: from 'bench to bedside' to the translational research 'valleys of death'.
    Tugwell P; Knottnerus JA
    J Clin Epidemiol; 2015 Jul; 68(7):725-6. PubMed ID: 26047303
    [No Abstract]   [Full Text] [Related]  

  • 13. The Prevention Research Centers program: translating research into public health practice and impact.
    Greenlund KJ; Giles WH
    Am J Prev Med; 2012 Sep; 43(3 Suppl 2):S91-2. PubMed ID: 22898167
    [No Abstract]   [Full Text] [Related]  

  • 14. Dissemination of Translational Research.
    Curtis J; DeMaio D
    Radiol Technol; 2017 Sep; 89(1):103-106. PubMed ID: 28904168
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical trial design and dissemination: comprehensive analysis of clinicaltrials.gov and PubMed data since 2005.
    Zwierzyna M; Davies M; Hingorani AD; Hunter J
    BMJ; 2018 Jun; 361():k2130. PubMed ID: 29875212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NIHR Alerts aim to help busy health and care professionals put research into practice.
    Saul H; Chatfield C
    BMJ; 2021 Oct; 375():n2445. PubMed ID: 34697070
    [No Abstract]   [Full Text] [Related]  

  • 17. Good pharma? Bad pharma? Better pharma.
    Hardman M
    J R Coll Physicians Edinb; 2014; 44(4):269-72. PubMed ID: 25516893
    [No Abstract]   [Full Text] [Related]  

  • 18. Maximizing usability of evidence in rehabilitation practice: tips for researchers.
    Sander AM; Van Veldhoven LM; Backus D
    Arch Phys Med Rehabil; 2013 Jan; 94(1 Suppl):S43-8. PubMed ID: 23127879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NIHR's research signals in
    Cook S; Lamont T; Cook R; Evans T; Davidson P
    BMJ; 2019 Feb; 364():l513. PubMed ID: 30760450
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of journal impact factor, reporting conflicts, and reporting funding sources, on standardized effect sizes in back pain trials: a systematic review and meta-regression.
    Froud R; Bjørkli T; Bright P; Rajendran D; Buchbinder R; Underwood M; Evans D; Eldridge S
    BMC Musculoskelet Disord; 2015 Nov; 16():370. PubMed ID: 26620449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.